Lactulose and Acetazolamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lactulose (lactulose) and Acetazolamide (acetazolamide). Common drug interactions include gastrointestinal disorder among females and toxic epidermal necrolysis among males.

The phase IV clinical study analyzes what interactions people have when they take Lactulose and Acetazolamide. It is created by eHealthMe based on reports of 85 people who take the same drugs from the FDA, and is updated regularly.

What is Lactulose?

Lactulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 46,960 Lactulose users. Check the latest studies of Lactulose.

What is Acetazolamide?

Acetazolamide has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 6,178 Acetazolamide users. Check the latest studies of Acetazolamide.



On Jul, 23, 2026

85 people who take Lactulose and Acetazolamide together, and have interactions are studied.

Lactulose and Acetazolamide drug interactions.

What are the common drug interactions of Lactulose and Acetazolamide, by gender? *:

female:

  1. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  2. Hypotension (abnormally low blood pressure)
  3. Hypoxia (low oxygen in tissues)
  4. Insomnia (sleeplessness)
  5. Migraine (headache)
  6. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
  7. Nervousness
  8. Pneumonia
  9. Pyrexia (fever)
  10. Urinary tract infection

male:

  1. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  2. Hepatic failure (liver failure)
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Haematoma (collection of blood outside the blood vessels)
  5. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  6. Pulmonary hypertension (increase in blood pressure in the lung artery)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Septic shock (shock due to blood infection)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the common drug interactions of Lactulose and Acetazolamide, by age (0-1 to 60+)? *:

0-1:

  1. Alanine aminotransferase increased
  2. Circulatory collapse
  3. Dehydration (dryness resulting from the removal of water)
  4. Diarrhoea
  5. Hepatic failure (liver failure)
  6. Lactic acidosis (low ph in body tissues)
  7. Renal failure (kidney dysfunction)

2-9:

  1. Alanine aminotransferase increased
  2. Anticonvulsant drug level increased
  3. Aspartate aminotransferase increased
  4. Asthenia (weakness)
  5. Bilirubin conjugated increased
  6. Blood alkaline phosphatase increased
  7. Blood bilirubin increased
  8. Blood creatine phosphokinase increased
  9. Blood pressure decreased
  10. Body temperature decreased

10-19:

n/a

20-29:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Suicide attempt
  3. Abdominal infection
  4. Abdominal pain upper
  5. Acidosis (build-up of carbon dioxide in the blood)
  6. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  7. Asthenia (weakness)
  8. Back pain
  9. Blood cholesterol increased
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

30-39:

  1. Pneumonia bacterial (pneumonia associated with bacterial infection)
  2. Asthenia (weakness)
  3. Cholecystitis acute (rapid infection of gallbladder)
  4. Dyspnoea (difficult or laboured respiration)
  5. Gastrointestinal necrosis (destruction of gastrointestinal organ)
  6. General physical health deterioration (weak health status)
  7. Hypercapnia (too much smoke)
  8. Intestinal perforation (complete penetration of the wall of the intestine)
  9. Liver disorder (liver diseases)
  10. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

40-49:

  1. Hepatic failure (liver failure)

50-59:

  1. Renal failure (kidney dysfunction)
  2. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Bacteraemia (presence of bacteria in the blood)
  6. Burkholderia test positive
  7. Deafness transitory (deafness temporary)
  8. Depression
  9. Ear infection
  10. Exfoliative rash (scaly red generalized skin rash)

60+:

  1. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Colitis (inflammation of colon)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  7. Tachypnoea (a condition of rapid breathing over 20 per minute)
  8. Back pain
  9. Burkholderia test positive
  10. Confusional state

What are the existing conditions these people have? *

  1. Stress And Anxiety: 19 people, 22.35%
  2. High Blood Pressure: 18 people, 21.18%
  3. Fever: 14 people, 16.47%
  4. Diarrhea: 13 people, 15.29%
  5. Depression: 12 people, 14.12%
  6. Sedation: 11 people, 12.94%
  7. Pneumonia: 11 people, 12.94%
  8. Pain: 11 people, 12.94%
  9. Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 10 people, 11.76%
  10. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 10 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Lactulose and Acetazolamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lactulose and Acetazolamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lactulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Acetazolamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lactulose and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acetazolamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lactulose and acetazolamide (the active ingredients of Lactulose and Acetazolamide, respectively), and Lactulose and Acetazolamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: